BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4800390)

  • 1. Neurological consequences of psychotropic drug withdrawal in schizophrenic children.
    Polizos P; Engelhardt DM; Hoffman SP; Waizer J
    J Autism Child Schizophr; 1973; 3(3):247-53. PubMed ID: 4800390
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind comparison of fluphenazine and haloperidol in outpatient schizophrenic children.
    Engelhardt DM; Polizos P; Waizer J; Hoffman SP
    J Autism Child Schizophr; 1973; 3(2):128-37. PubMed ID: 4583792
    [No Abstract]   [Full Text] [Related]  

  • 3. Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol.
    Levenson AJ; Burnett GB; Nottingham JD; Sermas CE; Thornby JI
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):695-700. PubMed ID: 825356
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-induced dystonia.
    Swett C
    Am J Psychiatry; 1975 May; 132(5):532-4. PubMed ID: 1119613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Affective disorders in the course of treatment with neuroleptics of children and adolescents with schizophrenia].
    Semanovskaia EI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(10):1529-34. PubMed ID: 4386295
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine.
    Kazamatsuri H; Chien CP; Cole JO
    Am J Psychiatry; 1973 Apr; 130(4):479-83. PubMed ID: 4570750
    [No Abstract]   [Full Text] [Related]  

  • 7. Are antipsychotic drugs interchangeable?
    Gardos G
    J Nerv Ment Dis; 1974 Nov; 159(5):343-8. PubMed ID: 4612111
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychiatric pharmacotherapy and the schizophrenic defect.
    Molcan J; Floreánová L; Novotný V; Polák L; Rakús A; Motýlová A
    Act Nerv Super (Praha); 1973 May; 15(2):91. PubMed ID: 4148088
    [No Abstract]   [Full Text] [Related]  

  • 9. Thiothixene in young disturbed children. A pilot study.
    Campbell M; Fish B; Shapiro T; Floyd A
    Arch Gen Psychiatry; 1970 Jul; 23(1):70-2. PubMed ID: 5447378
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of neuroleptics on attention in adolescent schizophrenics.
    Erickson WD; Yellin AM; Hopwood JH; Realmuto GM; Greenberg LM
    Biol Psychiatry; 1984 May; 19(5):745-53. PubMed ID: 6733182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double blind comparative study of the effects of thiothixene and thioridazine in twenty chronic schizophrenic patients.
    Hardeman WJ; Bakker SJ
    Psychiatr Neurol Neurochir; 1970; 73(1):1-7. PubMed ID: 4907371
    [No Abstract]   [Full Text] [Related]  

  • 12. Concurrent haloperidol withdrawal and benztropine overdose: a case report.
    West RR; Newgreen DB
    Compr Psychiatry; 1978; 19(6):557-60. PubMed ID: 720041
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents.
    Realmuto GM; Erickson WD; Yellin AM; Hopwood JH; Greenberg LM
    Am J Psychiatry; 1984 Mar; 141(3):440-2. PubMed ID: 6367494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single-blind evaluation of thiothixene with outpatient schizophrenic children.
    Waizer J; Polizos P; Hoffman SP; Engelhardt DM; Margolis RA
    J Autism Child Schizophr; 1972; 2(4):378-86. PubMed ID: 4679294
    [No Abstract]   [Full Text] [Related]  

  • 15. Prediction of improvement in schizophrenia under four phenothiazines.
    Goldberg SC; Mattsson N; Cole JO; Klerman GL
    Arch Gen Psychiatry; 1967 Jan; 16(1):107-17. PubMed ID: 6066689
    [No Abstract]   [Full Text] [Related]  

  • 16. Basic principles of rapid neuroleptization.
    Mason AS; Granacher RP
    Dis Nerv Syst; 1976 Oct; 37(10):547-51. PubMed ID: 9267
    [No Abstract]   [Full Text] [Related]  

  • 17. The abrupt withdrawal of antiparkinsonian drugs in schizophrenic patients.
    McClelland HA; Blessed G; Bhate S; Ali N; Clarke PA
    Br J Psychiatry; 1974 Feb; 124(579):151-9. PubMed ID: 4596671
    [No Abstract]   [Full Text] [Related]  

  • 18. Schizophrenic subtypes defined by response to drugs and placebo.
    Goldberg SC; Mattsson NB
    Dis Nerv Syst; 1968 May; 29(5):Suppl:153-8. PubMed ID: 4876985
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroleptics and the corpus striatum: clinical implications.
    Stimmel GL
    Dis Nerv Syst; 1976 Apr; 37(4):219-24. PubMed ID: 1253676
    [No Abstract]   [Full Text] [Related]  

  • 20. Tardive and withdrawal dyskinesia associated with haloperidol.
    Jacobson G; Baldessarini RJ; Manschreck T
    Am J Psychiatry; 1974 Aug; 131(8):910-3. PubMed ID: 4834709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.